List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 2623 studies with search of: stage 2 breast cancer
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Vaccine Therapy in Combination With Ampligen® and/or Sargramostim in Patients With Stage II-IV HER2-Positive Breast Cancer
Conditions: HER2-positive Breast Cancer;   Male Breast Cancer;   Recurrent Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: Ampligen;   Biological: synthetic HER-2/neu peptide vaccine;   Biological: GM-CSF;   Other: laboratory biomarker analysis;   Other: immunoenzyme technique
2 Recruiting Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: goserelin acetate;   Drug: letrozole;   Drug: anastrozole;   Procedure: therapeutic conventional surgery;   Genetic: DNA analysis;   Other: immunohistochemistry staining method;   Procedure: positron emission tomography;   Genetic: comparative genomic hybridization;   Procedure: biopsy;   Other: laboratory biomarker analysis;   Drug: chemotherapy
3 Active, not recruiting Combination Chemotherapy and Bevacizumab in Treating Women With HER2/Neu-Negative Stage II or Stage III Breast Cancer
Conditions: HER2-negative Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: doxorubicin hydrochloride;   Drug: cyclophosphamide;   Biological: bevacizumab;   Drug: paclitaxel;   Drug: gemcitabine hydrochloride;   Other: laboratory biomarker analysis;   Biological: pegfilgrastim
4 Recruiting Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer
Conditions: Stage II Breast Cancer;   Stage III Breast Cancer
Intervention: Biological: Autologous dendritic cell vaccination. Dendritic cells are pulsed with their own tumor antigens
5 Recruiting Pazopanib Hydrochloride and Anastrozole Before Surgery in Treating Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Male Breast Cancer;   Recurrent Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer
Interventions: Drug: anastrozole;   Drug: pazopanib hydrochloride;   Procedure: therapeutic conventional surgery
6 Recruiting Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm
Conditions: Breast Cancer;   Chemotherapy
Interventions: Drug: Taxotere , Epirubine;   Drug: E-HDFL,EP,TE,N-HDFL,NP,T-HDFL,TP
7 Recruiting Laboratory-Treated T Cells After Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer Undergoing Surgery
Condition: Breast Cancer
Interventions: Biological: HER2Bi-armed activated T cells;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel;   Other: laboratory biomarker analysis;   Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery
8 Active, not recruiting Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel;   Drug: tamoxifen citrate;   Procedure: adjuvant therapy;   Radiation: radiation therapy
9 Completed Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Biological: aldesleukin;   Biological: recombinant interferon gamma;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: thiotepa;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
10 Recruiting Study to Compare the Efficacy and Finally Cure Rate With or Without Carboplatin on Medium to High Risk Patients With Triple Negative or Her2positive Breast Cancer. Patients Will Receive the Carboplatin Treatment as add-on to Standard Chemotherapy Combined With Small Molecules
Conditions: Tubular Breast Cancer Stage II;   Mucinous Breast Cancer Stage II;   Breast Cancer Female NOS;   Invasive Ductal Breast Cancer;   Tubular Breast Cancer Stage III;   HER-2 Positive Breast Cancer;   Inflammatory Breast Cancer Stage IV;   Inflammatory Breast Cancer
Interventions: Drug: Carboplatin;   Drug: background treatment according to standards fpr triple negative and Her2pos breast cancer patients
11 Completed Biomarkers in Women Receiving Chemotherapy and Celecoxib for Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Drug: capecitabine;   Drug: celecoxib;   Drug: cyclophosphamide;   Drug: docetaxel;   Drug: doxorubicin hydrochloride;   Genetic: gene expression analysis;   Genetic: polymorphism analysis;   Genetic: protein expression analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: imaging biomarker analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: pharmacogenomic studies;   Procedure: dynamic contrast-enhanced magnetic resonance imaging;   Procedure: needle biopsy;   Procedure: neoadjuvant therapy;   Procedure: radiomammography;   Procedure: ultrasound imaging
12 Completed RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097;   Drug: letrozole;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: breast biopsy;   Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery
13 Completed Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients
Condition: Breast Neoplasm
Interventions: Drug: epirubicin;   Drug: cyclophosphamide;   Drug: docetaxel;   Drug: trastuzumab
14 Recruiting Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer Patients
Condition: Breast Cancer
Interventions: Drug: DLBS1425;   Drug: Placebo DLBS1425
15 Recruiting Docetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage III Breast Cancer That Can Be Removed by Surgery
Condition: Breast Cancer
Interventions: Biological: trastuzumab;   Drug: carboplatin;   Drug: docetaxel;   Drug: lapatinib ditosylate
16 Withdrawn Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer
Conditions: Ductal Breast Carcinoma in Situ;   Estrogen Receptor-negative Breast Cancer;   Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   HER2-positive Breast Cancer;   Invasive Ductal Breast Carcinoma;   Invasive Lobular Breast Carcinoma;   Male Breast Cancer;   Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate;   Mucinous Ductal Breast Carcinoma;   Papillary Ductal Breast Carcinoma;   Progesterone Receptor-negative Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Stage I Breast Cancer;   Stage II Breast Cancer;   Tubular Ductal Breast Carcinoma
Interventions: Radiation: external beam radiation therapy;   Other: questionnaire administration;   Procedure: therapeutic conventional surgery
17 Completed Phase II Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer
Conditions: Breast Cancer;   Carcinoma Breast Stage IV
Interventions: Drug: Lapatinib;   Drug: Doxorubicin;   Drug: Cyclophosphamide;   Drug: Docetaxel;   Drug: pegfilgrastim;   Drug: filgrastim;   Drug: dexamethasone;   Drug: trastuzumab
18 Active, not recruiting Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: anastrozole;   Drug: exemestane;   Drug: letrozole
19 Active, not recruiting Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Drug: CMF regimen;   Drug: docetaxel;   Drug: doxorubicin hydrochloride;   Drug: tamoxifen citrate;   Procedure: autologous bone marrow transplantation;   Procedure: surgical procedure;   Radiation: radiation therapy
20 Unknown † Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer
Condition: Breast Cancer
Interventions: Biological: trastuzumab;   Drug: aromatase inhibition therapy;   Drug: cyclophosphamide;   Drug: docetaxel;   Drug: doxorubicin hydrochloride;   Drug: epirubicin hydrochloride;   Drug: fluorouracil;   Drug: paclitaxel;   Drug: releasing hormone agonist therapy;   Drug: tamoxifen citrate;   Procedure: adjuvant therapy;   Radiation: radiation therapy

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services